187 related articles for article (PubMed ID: 27475101)
1. Release of PACAP-38 in episodic cluster headache patients - an exploratory study.
Tuka B; Szabó N; Tóth E; Kincses ZT; Párdutz Á; Szok D; Körtési T; Bagoly T; Helyes Z; Edvinsson L; Vécsei L; Tajti J
J Headache Pain; 2016 Dec; 17(1):69. PubMed ID: 27475101
[TBL] [Abstract][Full Text] [Related]
2. Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients.
Tuka B; Helyes Z; Markovics A; Bagoly T; Szolcsányi J; Szabó N; Tóth E; Kincses ZT; Vécsei L; Tajti J
Cephalalgia; 2013 Oct; 33(13):1085-95. PubMed ID: 23598374
[TBL] [Abstract][Full Text] [Related]
3. Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache.
Han X; Dong Z; Hou L; Wan D; Chen M; Tang W; Yu S
Clin Chim Acta; 2015 Oct; 450():151-4. PubMed ID: 26296898
[TBL] [Abstract][Full Text] [Related]
4. Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system.
Tuka B; Helyes Z; Markovics A; Bagoly T; Németh J; Márk L; Brubel R; Reglődi D; Párdutz A; Szolcsányi J; Vécsei L; Tajti J
Peptides; 2012 Feb; 33(2):307-16. PubMed ID: 22245521
[TBL] [Abstract][Full Text] [Related]
5. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
[TBL] [Abstract][Full Text] [Related]
6. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
[TBL] [Abstract][Full Text] [Related]
7. Cranial parasympathetic activation induces autonomic symptoms but no cluster headache attacks.
Guo S; Petersen AS; Schytz HW; Barløse M; Caparso A; Fahrenkrug J; Jensen RH; Ashina M
Cephalalgia; 2018 Jul; 38(8):1418-1428. PubMed ID: 29082824
[TBL] [Abstract][Full Text] [Related]
8. PACAP-38 related modulation of the cranial parasympathetic projection: A novel mechanism and therapeutic target in severe primary headache.
Akerman S; Goadsby PJ; Romero-Reyes M
Br J Pharmacol; 2024 Feb; 181(3):480-494. PubMed ID: 37706270
[TBL] [Abstract][Full Text] [Related]
9. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
10. No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.
Cernuda-Morollón E; Riesco N; Martínez-Camblor P; Serrano-Pertierra E; García-Cabo C; Pascual J
Headache; 2016 Oct; 56(9):1448-1454. PubMed ID: 27634731
[TBL] [Abstract][Full Text] [Related]
11. Expression of messenger molecules and receptors in rat and human sphenopalatine ganglion indicating therapeutic targets.
Steinberg A; Frederiksen SD; Blixt FW; Warfvinge K; Edvinsson L
J Headache Pain; 2016 Dec; 17(1):78. PubMed ID: 27587062
[TBL] [Abstract][Full Text] [Related]
12. Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats.
Han X; Ran Y; Su M; Liu Y; Tang W; Dong Z; Yu S
Mol Pain; 2017; 13():1744806917720361. PubMed ID: 28776455
[TBL] [Abstract][Full Text] [Related]
13. Presence of pituitary adenylate cyclase-activating polypeptide (PACAP) in the plasma and milk of ruminant animals.
Czegledi L; Tamas A; Borzsei R; Bagoly T; Kiss P; Horvath G; Brubel R; Nemeth J; Szalontai B; Szabadfi K; Javor A; Reglodi D; Helyes Z
Gen Comp Endocrinol; 2011 May; 172(1):115-9. PubMed ID: 21185294
[TBL] [Abstract][Full Text] [Related]
14. The change of plasma pituitary adenylate cyclase-activating polypeptide levels after aneurysmal subarachnoid hemorrhage.
Jiang L; Wang WH; Dong XQ; Yu WH; Du Q; Yang DB; Wang H; Shen YF
Acta Neurol Scand; 2016 Aug; 134(2):131-9. PubMed ID: 26471292
[TBL] [Abstract][Full Text] [Related]
15. Calcitonin-gene related peptide and disease activity in cluster headache.
Snoer A; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Fahrenkrug J; Jørgensen NR; Martinussen T; Jensen RH; Ashina M
Cephalalgia; 2019 Apr; 39(5):575-584. PubMed ID: 30854880
[TBL] [Abstract][Full Text] [Related]
16. Sphenopalatine ganglion volumetry in episodic cluster headache: from symptom laterality to cranial autonomic symptoms.
Wu JW; Chen ST; Wang YF; Lai KL; Chen TY; Chen SP; Chen WT; Wang SJ
J Headache Pain; 2023 Jan; 24(1):2. PubMed ID: 36597044
[TBL] [Abstract][Full Text] [Related]
17. Plasma pituitary adenylate cyclase-activating polypeptide concentrations and mortality after acute spontaneous basal ganglia hemorrhage.
Ma BQ; Zhang M; Ba L
Clin Chim Acta; 2015 Jan; 439():102-6. PubMed ID: 25314937
[TBL] [Abstract][Full Text] [Related]
18. Presence of pituitary adenylate cyclase activating polypeptide-38 in human plasma and milk.
Borzsei R; Mark L; Tamas A; Bagoly T; Bay C; Csanaky K; Banki E; Kiss P; Vaczy A; Horvath G; Nemeth J; Szauer E; Helyes Z; Reglodi D
Eur J Endocrinol; 2009 Apr; 160(4):561-5. PubMed ID: 19174531
[TBL] [Abstract][Full Text] [Related]
19. PACAP-38 and sex hormones in women with migraine: exploratory analysis of a cross-sectional, matched cohort study.
Storch E; Overeem LH; Terhart M; Fitzek MP; Lange KS; Reuter U; Raffaelli B
J Headache Pain; 2024 Jun; 25(1):98. PubMed ID: 38858641
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of VIP are not elevated during PACAP- and VIP-induced cluster headache attacks: an exploratory study.
Deligianni C; Pellesi L; Chaudhry BA; Haulund Vollesen AL; Snoer AH; Hannibal J; Jensen RH; Ashina M
Front Neurol; 2023; 14():1135246. PubMed ID: 37143998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
